TY - JOUR
T1 - Role of a prudent breakfast in improving cardiometabolic risk factors in subjects with hypercholesterolemia
T2 - A randomized controlled trial
AU - Adamsson, Viola
AU - Reumark, Anna
AU - Marklund, Matti
AU - Larsson, Anders
AU - Risérus, Ulf
N1 - Publisher Copyright:
© 2014 The Authors.
PY - 2015/2/1
Y1 - 2015/2/1
N2 - Background & aims: It is unclear whether advising a prudent breakfast alone is sufficient to improve blood lipids and cardiometabolic risk factors in overweight hypercholesterolemic subjects. The aim of this study was to investigate whether a prudent low-fat breakfast (PB) rich in dietary fiber lowers low-density lipoprotein cholesterol (LDL-C) and other cardiometabolic risk factors in subjects with elevated LDL-cholesterol levels. Methods: In a parallel, controlled, 12-week study, 79 healthy overweight subjects (all regular breakfast eaters) were randomly allocated to a group that received a PB based on Nordic foods provided ad libitum or a control group that consumed their usual breakfast. The primary outcome was plasma LDL-C. Secondary outcomes were other blood lipids, body weight, sagittal abdominal diameter (SAD), glucose tolerance, insulin sensitivity and inflammation markers (C-reactive protein [CRP] and tumor necrosis factor receptor-2 [TNF-R2]), and blood pressure. The PB was in accordance with national and Nordic nutrition recommendations and included oat bran porridge with low-fat milk or yogurt, bilberry or lingonberry jam, whole grain bread, low-fat spread, poultry or fatty fish, and fruit. Results: No differences were found in LDL-C, other blood lipids, body weight, or glucose metabolism, but SAD, plasma CRP, and TNF-R2 decreased more during PB compared with controls (p<0.05). In the overall diet, PB increased dietary fiber and β-glucan compared with controls (p<0.05). Conclusions: Advising a prudent breakfast for 3 months did not influence blood lipids, body weight, or glucose metabolism but reduced markers of visceral fat and inflammation.
AB - Background & aims: It is unclear whether advising a prudent breakfast alone is sufficient to improve blood lipids and cardiometabolic risk factors in overweight hypercholesterolemic subjects. The aim of this study was to investigate whether a prudent low-fat breakfast (PB) rich in dietary fiber lowers low-density lipoprotein cholesterol (LDL-C) and other cardiometabolic risk factors in subjects with elevated LDL-cholesterol levels. Methods: In a parallel, controlled, 12-week study, 79 healthy overweight subjects (all regular breakfast eaters) were randomly allocated to a group that received a PB based on Nordic foods provided ad libitum or a control group that consumed their usual breakfast. The primary outcome was plasma LDL-C. Secondary outcomes were other blood lipids, body weight, sagittal abdominal diameter (SAD), glucose tolerance, insulin sensitivity and inflammation markers (C-reactive protein [CRP] and tumor necrosis factor receptor-2 [TNF-R2]), and blood pressure. The PB was in accordance with national and Nordic nutrition recommendations and included oat bran porridge with low-fat milk or yogurt, bilberry or lingonberry jam, whole grain bread, low-fat spread, poultry or fatty fish, and fruit. Results: No differences were found in LDL-C, other blood lipids, body weight, or glucose metabolism, but SAD, plasma CRP, and TNF-R2 decreased more during PB compared with controls (p<0.05). In the overall diet, PB increased dietary fiber and β-glucan compared with controls (p<0.05). Conclusions: Advising a prudent breakfast for 3 months did not influence blood lipids, body weight, or glucose metabolism but reduced markers of visceral fat and inflammation.
KW - Cardiometabolic risk factors
KW - Inflammation
KW - LDL-cholesterol
KW - Nordic diet
KW - Prudent breakfast
KW - Visceral fat
UR - http://www.scopus.com/inward/record.url?scp=84921434261&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84921434261&partnerID=8YFLogxK
U2 - 10.1016/j.clnu.2014.04.009
DO - 10.1016/j.clnu.2014.04.009
M3 - Article
C2 - 24814382
AN - SCOPUS:84921434261
SN - 0261-5614
VL - 34
SP - 20
EP - 26
JO - Clinical Nutrition
JF - Clinical Nutrition
IS - 1
ER -